TY - JOUR
T1 - Techniques of extracorporeal cytokine removal: a systematic review of human studies
AU - Atan, Rafidah
AU - Crosbie, David C A
AU - Bellomo, Rinaldo
PY - 2013
Y1 - 2013
N2 - Background and aims: Hypercytokinemia is believed to be harmful and reducing cytokine levels
is considered beneficial. Extracorporeal blood purification (EBP) techniques have been studied
for the purpose of cytokine reduction. We aimed to study the efficacy of various EBP techniques
for cytokine removal as defined by technical measures. Method: We conducted a systematic
search for human clinical trials which focused on technical measures of cytokine removal by
EBP techniques. We identified 41 articles and analyzed cytokine removal according to clearance
(CL), sieving coefficient (SC), ultrafiltrate (UF) concentration and percentage removed. Results:
We identified the following techniques for cytokine removal: standard hemofiltration, high
volume hemofiltration (HVHF), high cut-off (HCO) hemofiltration, plasma filtration techniques,
and adsorption techniques, ultrafiltration (UF) techniques relating to cardiopulmonary bypass
(CPB), extracorporeal liver support systems and hybrid techniques including combined plasma
filtration adsorption. Standard filtration techniques and UF techniques during CPB were
generally poor at removing cytokines (median CL for interleukin 6 [IL-6]: 1.09 mL/min,
TNF-alpha 0.74 mL/min). High cut-off techniques consistently offered moderate cytokine
removal (median CL for IL-6: 26.5 mL/min, interleukin 1 receptor antagonist [IL-1RA]: 40.2 mL/
min). Plasma filtration and extracorporeal liver support appear promising but data are few. Only
one paper studied combined plasma filtration and adsorption and found low rates of removal.
The clinical significance of the cytokine removal achieved with more efficacious techniques is
unknown. Conclusion: Human clinical trials indicate that high cut-off hemofiltration techniques,
and perhaps plasma filtration and extracorporeal liver support techniques are likely more
efficient in removing cytokines than standard techniques.
AB - Background and aims: Hypercytokinemia is believed to be harmful and reducing cytokine levels
is considered beneficial. Extracorporeal blood purification (EBP) techniques have been studied
for the purpose of cytokine reduction. We aimed to study the efficacy of various EBP techniques
for cytokine removal as defined by technical measures. Method: We conducted a systematic
search for human clinical trials which focused on technical measures of cytokine removal by
EBP techniques. We identified 41 articles and analyzed cytokine removal according to clearance
(CL), sieving coefficient (SC), ultrafiltrate (UF) concentration and percentage removed. Results:
We identified the following techniques for cytokine removal: standard hemofiltration, high
volume hemofiltration (HVHF), high cut-off (HCO) hemofiltration, plasma filtration techniques,
and adsorption techniques, ultrafiltration (UF) techniques relating to cardiopulmonary bypass
(CPB), extracorporeal liver support systems and hybrid techniques including combined plasma
filtration adsorption. Standard filtration techniques and UF techniques during CPB were
generally poor at removing cytokines (median CL for interleukin 6 [IL-6]: 1.09 mL/min,
TNF-alpha 0.74 mL/min). High cut-off techniques consistently offered moderate cytokine
removal (median CL for IL-6: 26.5 mL/min, interleukin 1 receptor antagonist [IL-1RA]: 40.2 mL/
min). Plasma filtration and extracorporeal liver support appear promising but data are few. Only
one paper studied combined plasma filtration and adsorption and found low rates of removal.
The clinical significance of the cytokine removal achieved with more efficacious techniques is
unknown. Conclusion: Human clinical trials indicate that high cut-off hemofiltration techniques,
and perhaps plasma filtration and extracorporeal liver support techniques are likely more
efficient in removing cytokines than standard techniques.
UR - http://informahealthcare.com/doi/pdf/10.3109/0886022X.2013.815089
UR - https://www.scopus.com/pages/publications/84881598949
U2 - 10.3109/0886022X.2013.815089
DO - 10.3109/0886022X.2013.815089
M3 - Article
SN - 0886-022X
VL - 35
SP - 1061
EP - 1070
JO - Renal Failure
JF - Renal Failure
IS - 8
ER -